Cofilin 1 Active human, recombinant, expressed in E. coli, >=90% (SDS-PAGE)

Code: srp0254-200ug D2-231

Not available outside of the UK & Ireland.

Application

Kinase substrate for the kinase assay; western blot

Biochem/physiol Actions

Cofilin-l (CFL1) plays a vital role in the regulation of ...


read more

Your Price
$712.65 200UG

Not available outside of the UK & Ireland.

Application

Kinase substrate for the kinase assay; western blot

Biochem/physiol Actions

Cofilin-l (CFL1) plays a vital role in the regulation of actin cytoskeleton reorganization. It is also implicated in cancer cell migration and invasion in several types of tumor tissues. Elevated expression of the gene is associated with the development of esophageal squamous cell carcinoma (ESCC). In addition, abnormal expression of the gene leads to vulvar cancer and thus, it can be considered as a potential therapeutic target for the same. CFL1 facilitates cytokinesis, cell motility and morphogenesis. Activated CFL1 helps in preventing cytoskeletal-associated defects in axonal development stimulated by Syns.

General description

Cofilin 1 is ubiquitously expressed and has a molecular mass of ~19kDa.

Human recombinant Cofilin1 (2-end) with N-terminal GST tag (GenBank Accession No. NM_005507), expressed in a E. coli expression system. Cofilin 1, MW = 44 kDa,

Physical form

Formulated in 25 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.05% Tween-20, 30% glycerol and 3 mM DTT.

Preparation Note

Thaw on ice. Upon first thaw, briefly spin tube containing enzyme to recover full content of the tube. Aliquot enzyme into single use aliquots. Store remaining undiluted enzyme in aliquots at -70°C. Note: Enzyme is very sensitive to freeze/thaw cycles.

assay≥90% (SDS-PAGE)
biological sourcehuman
concentration>0.02 mg/mL
formaqueous solution
Gene Informationhuman ... CFL1(1072)
mol wt44 kDa
NCBI accession no.NM_005507
packagingpkg of 200 µg
recombinantexpressed in E. coli
shipped indry ice
storage temp.−70°C
UniProt accession no.P23528
This product has met the following criteria: